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Electrospray ionization (ESI) mass spectrometry (MS) has proven to be an extremely powerful
technique for studying the stoichiometry and binding strength of peptide–metal complexes.
We have found a significant new problem in the ESI-MS of zinc–peptide systems involving the
deposition of zinc in the ESI emitter. This deposition of zinc during the experiment removes
a significant amount of zinc ions from the solution, impacting the resulting mass spectral
intensities used to quantify the amount of the zinc-bound species. Analysis of infused
zinc–peptide samples with atomic absorption spectrometry and with a custom-built nanoflow
ESI source confirms the alteration of the analyte solutions with positive or negative or no
potential applied to the emitter. Ultimately, the location of the zinc deposition was determined
to be the stainless steel emitter. The use of a custom-built nanoESI interface using glass
emitters was found to mitigate the zinc deposition problem. The phenomenon of metal
deposition warrants further investigation as it may not be limited to just zinc and may
represent a significant obstacle in the ESI-MS analysis of all protein-metal systems. (J Am Soc
Mass Spectrom 2009, 20, 2199–2205) © 2009 American Society for Mass SpectrometryThere is wide interest across disciplines in character-izing the structure and function of metal-bindingbiomolecules. Although not all systems are amena-
ble to study by a single technique, mass spectrometry has
been recognized as a powerful method for determining
the stoichiometry and binding strength of metal–
peptide or metal–protein complexes [1, 2]. This is espe-
cially true for spectroscopically silent (d10) metal ions
such as Zn2 and Cd2 [3–8]. Many important sample-
related and instrumental factors must be considered
when making these types of measurements. Careful
selection of standardized reagents and characterization
of the concentrations of resulting solutions are neces-
sary when quantitative work is to be performed [9].
Specific mass spectrometric considerations such as the
ionization and transfer efficiencies of apo and holo
peptides must be considered [2]. Arguably, one of the
most important issues is considering oxidation and
reduction activity during sample preparation and ion-
ization. Rigorous control of pH, temperature, and ex-
posure to air is required. Anticipating or preventing
compensatory electrolytic deposition of metal ions (re-
duction in negative mode ESI and oxidation in positive)
as well as oxidation of residues such as cysteine during
positive ESI is crucial [10–14].
We have found a significant new problem in the ESI
process of zinc–peptide systems that may contribute to
discrepancies in the mass spectral intensities used to
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in a sample. In turn, these data could not be reliably
used for reporting dissociation constants (Kd) measured
with mass spectrometry. We have observed, under a
variety of conditions, carryover of zinc from one exper-
iment to the next. Thorough cleaning with mildly acidic
solution certainly solves the intermediate carryover
problem between sample analyses. However, we have
measured significant changes in relative zinc content
in solution before and after short (minutes) ESI-MS
experiments. This observation indicates a measurable
amount of zinc is lost from solution during the mass
spectrometry experiment, which alters the mass spec-
tral data used to determine features of the zinc–
peptide complex. We performed several experiments
to investigate this phenomenon further, and have
learned zinc loss occurs regardless of the ESI polarity
used or the binding strength of the peptide. We also
investigated the effect of infusion rate on the amount
of zinc lost from solution, and will present the use of
nanoESI as both a characterization method and, po-
tentially, a method to solve this problem.
Experimental
Experiments were performed on Bruker EsquireLC and
Bruker Esquire 3000plus Quadrupole Ion Trap Mass
Spectrometers (Bruker Daltonics, Billerica, MA). The
same ESI emitter assembly, shown in Figure 1, was used
on both instruments. Sample was infused with a KD
Scientific syringe pump at 0.250 mL/h unless otherwise
noted. Sample is introduced with a 250 L Hamilton no.
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needle into a Rheodyne needle port lined with a Teflon
liner tube. The port is connected to 75 cm of 0.005 in.
i.d. polyetheretherketone (PEEK) tubing via a 1/16 in.
zero dead volume union. Another union is used to
connect the other end of the PEEK tubing to the liquid
inlet shown in Figure 1. Inside the electrospray nebu-
lizer sits the ESI emitter, constructed of stainless steel
(approximately 9 cm long; 0.10 mm i.d., 0.17 mm o.d. at
tapered end). This ESI assembly was originally sold
with the Esquire 3000plus mass spectrometer but is also
available separately (part no. G1946; Agilent Technolo-
gies, Wilmington, DE). Sample travels from the syringe,
through PEEK tubing, and then the stainless steel
emitter. It is sampled off-axis into the glass transfer
capillary shown in Figure 1.
The nanoESI source was constructed in-house. The
nanoESI emitters are constructed from borosilicate glass
capillaries (0.58 mm i.d., 1.0 mm o.d.), which are drawn
to a fine tip (5–10 m i.d.) with a Sutter P-97 Flaming/
Brown micropipette puller (Novato, CA). The nanoESI
emitter is directed at the aperture of the glass transfer
capillary. Since the nanoESI emitters are not metallized,
a platinum wire (0.10 mm diameter; Sigma Aldrich, St.
Louis, MO) is inserted into the open end of the emitter
to provide electrical contact to ground the solution in
the emitter. For both ESI and nanoESI sources, the
emitter is grounded and the spray potential is applied
to the counterelectrode at the opening of the source. The
Figure 1. Schematic of the electrospray ionization source. See the
Experimental section for more detail.electric potential used to initiate ESI was 3.5 to 4.0 kV,and 700 to 1000 V for nanoESI. The source conditions
were optimized to minimize fragmentation. The most
important parameter in this optimization was the set-
ting of the capillary exit-skimmer potential difference to
126 V. The dry gas flow was 5 L/min at 250 °C for ESI
and 1 L/min at 30 °C for nanoESI, and the nebulizer gas
pressure was 10 psi for ESI, but was not used for
nanoESI.
Flame atomic absorption spectrophotometry experi-
ments were performed on a Perkin Elmer AAnalyst 200
(Waltham, MA). The 213.86 nm line of a zinc hollow
cathode lamp was used as the source, and background
subtraction was performed. A spacer typically inserted
before the impact bead in the nebulizer was removed to
increase sensitivity. The limit of detection for zinc in
this mode of operation is0.10 M, and the response is
linear to 12 M. Before analysis, 20 L of 6 N nitric acid
was added to the original 500 L aliquots of peptide:
metal sample, which were then diluted to 5.0 mL. The
nitric acid was added to sample solutions to release any
zinc bound to peptide so that elemental zinc could be
introduced in the atomic spectrometer.
The putative zinc binding region of the protein
prothymosin-, Ac-WEVD(E)5GG(E)8GDGEEEDGDE-
DEEAESATGKR-NH2 (ProT(50-89)N50W, hereafter
called ProT) was synthesized and purified as previ-
ously described [15]. The zinc finger (Cys4) peptide,
KLCEGGCGGCGGCGGW-NH2, was obtained from
Biopeptide (San Diego, CA), and the phytochelatin
(PC4) with the sequence (EC)4-G was obtained from
Anaspec (San Jose, CA). Both purchased peptides were
purified by the manufacturer and used directly.
Sample solutions were prepared at 5 to 10 M peptide
concentrations in 10/90 (vol/vol) methanol/water buff-
ered to pH  7 with 2 mM N-ethylmorpholine for ProT
or 20–25 mM ammonium acetate for the other peptides.
Concentrations of peptides containing tryptophan resi-
dues, ProT, and Cys4 were determined using UV spec-
trophotometry at 280 nm. Molar equivalents of zinc chlo-
ride (99.6%, ACS Certified Reagent; Fisher Scientific, Fair
Lawn, NJ) were added at varied amounts, as stated in the
text, and solutions were heated to 50 °C, shaken for 1 h,
and then centrifuged before MS analysis.
Results/Discussion
We have analyzed several zinc-binding peptides using
ESI-MS, and the same carryover of zinc metal in the
source was observed for all species studied. One of the
systems examined is a zinc finger peptide called Cys4,
which strongly binds one zinc ion at pH 7 (Kd 8.0 pM)
[16]. Contamination of the source with zinc was ob-
served when a solution of only the Cys4 peptide was
infused, but the Cys4:Zn2 complex was detected. First,
using positive mode ESI, a “clean” spectrum of 5 M
Cys4 was obtained, as shown in Figure 2a. Singly- and
doubly-charged Cys4 ions appear, as well as low inten-
sity peaks related to the buffered solvent system below
m/z 500. No significant fragment ions were detected,
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to work with noncovalent complexes. Zinc was intro-
duced by infusing a solution of 5 M Cys4 and 10 M
Zn2 (1:2 Cys4:Zn2), and any precipitated zinc was
centrifuged out of this solution before infusion. A
representative spectrum is shown in Figure 2b. This
solution was infused for approximately 5 min at 0.250
mL/h, which corresponds to introducing about 21 L
of solution, or about 10 nmol of Cys4 and 20 nmol Zn2.
The percent of peptide signal found in the zinc-bound
form can be calculated from the intensities of the Cys4
and Cys4:Zn2 signals in the mass spectrum, using eq 1:
ICys4:Zn2
ICys4  ICys4:Zn2
 100 (1)
At 2.0 M equivalents of zinc added to the solution, we
would expect to measure 100% of the peptide signal in
the Cys4:Zn2 state. Figure 2b shows that 87% of the
peptide was detected bound to Zn2.
After electrospraying the 1:2 Cys4:Zn2 solution, the
syringe, transfer line, and stainless steel emitter were
cleaned with 750 L (three 250 L syringefuls) of water,
our typical cleaning protocol. Although a dilute acid
solution was incorporated at a later point to better rid
the source of any leftover metal, at this point in the
experiments a simple aqueous flush was used. Since the
total volume of solution occupying the transfer/infu-
sion lines is under 10 L, using over 75 times this
volume in water to flush the lines was thought to be a
reasonable protocol. But it was under these cleaning
Figure 2. Mass spectra of (a) 10 M Cys4, (b) 1:2 (10 M and 20
M) Cys4:Zn2, and (c) 10 M Cys4 after infusing the solution
used to obtain the spectrum in (b). The (M  Zn)2 isotopic
distribution is magnified in panel (c).conditions that we realized that a significant amount ofzinc from the previous solution was being left behind
somewhere in the ESI source. This was detected when a
solution containing only 5 M Cys4 was infused, but
peaks corresponding to the 1 and 2 charge states of
Cys4:Zn2 persisted in the mass spectra for 40 min,
slowly decreasing with time. Figure 2c shows a repre-
sentative mass spectrum acquired during that period
(about 8 min after initiating the spray), when 27% of the
peptide was detected bound to Zn2. The initial appear-
ance and then decline in Cys4:Zn2 signal indicates that
zinc was being introduced to the apo-peptide solution
during analysis, and that the zinc supply was being
depleted over time.
We were initially tempted to attribute our zinc
carryover problems to uncontrolled redox processes.
Redox active metals are known to electrolytically de-
posit to compensate for charge imbalance during the
ESI process [11, 17–20]. But because so much high
quality work has been done over the last ten years in
understanding the redox processes, which can occur
during ESI of solutions containing redox active metal
ions, peptide ions, or both, several observations from
our experiments can be used to rule out redox phenom-
ena as a cause. First, positive mode ESI was used for
infusing both the Cys4:Zn2 and Cys4 solutions. Zinc
should remain in the Zn2 oxidation state during pos-
itive mode ESI, so it should not electrolytically deposit.
In fact, ESI emitters constructed of zinc have been used
to show that compensatory oxidation of the zinc to
Zn2 occurs in positive mode ESI [21]. Second, the
polarity of the ESI potential was not changed at any
point during this sequence of experiments, which
would be a requirement for releasing electrolytically
deposited metals. Consequently, we began to suspect
we were observing a surface effect somewhere along
the line in our source or mass spectrometer, and thus
began methodically switching out parts from another
instrument that was not used for metal analysis. Spe-
cifically, it was suspected that the PEEK transfer lines,
the electrospray needle, or the glass transfer capillary
(see Figure 1) could have been the site where some sort
of deposition of Zn2 was occurring. Thus, we again
monitored for zinc carryover from previously infused
Cys4:Zn2 solutions. This was achieved by flushing the
system with copious amounts of water followed by
Cys4, and the Cys4:Zn2 signal was still observed.
These experiments were performed using each of the
“clean” components individually substituted into the
instrument during the Cys4 infusion. While an excess of
Zn2 was used to generate Figure 2, during the subse-
quent experiments the deposition was observed when
equivalent or even substoichiometric amounts of metal
were used. Ultimately, the location of the zinc deposi-
tion was determined to be the stainless steel emitter,
because Cys4:Zn2 signal was not observed when a
“clean” Agilent nebulizer assembly was installed.
We do not attribute the observed behavior to reduc-
tion of the Zn2 ion because of the oxidizing conditions
of positive mode ESI. However, we could not rule out
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unless we worked under reducing conditions as well.
Since Cys4 is amenable to negative mode ESI as well,
we were able to reproduce the same carryover of zinc
when analogous negative polarity experiments were
conducted (data not shown). Thus, the phenomenon is
independent of polarity, although from these experi-
ments we could not determine whether the spray po-
tential itself played a role, or whether the Cys4 peptide
sequence or binding affinity influenced the process.
An offline quantitative analysis scheme was devised
to measure the zinc content of solutions before and after
infusion through the source assembly, in the absence of
applied ESI potential. This approach allows us to deter-
mine if the ESI potential is in fact necessary to observe
this phenomenon. If the ESI potential is not required,
AAS provides a straightforward method to simply
determine what percentage of zinc originally dissolved
in an analyte solution is removed during infusion
through the ESI source, without requiring ionization
and vaporization of the analyte. Five hundred L
aliquots of 10 MCys4 and 10 MZn2 (1:1 Cys4:Zn2)
were infused at several different flow rates in positive
ESI mode: 0.250, 1.00, and 2.00 mL/h. Because no
nebulizing gas or ESI potential was used to generate
electrospray, the solutions slowly dripped out of the
emitter into a plastic collection vial, which was sur-
rounding the emitter exit to avoid any sample loss.
Between infusions, the stainless steel emitter was
cleaned with 250 L 2% acetic acid and 2.5 mL 0.5%
acetic acid to rid it of zinc. (It was found that the acidic
wash was more effective in ridding the emitter of zinc
than the use of a chelator such as EDTA.) Then, the
emitter was flushed with 7.5 mL water or until the pH
of the solution exiting the emitter did not deviate from
pH 7. The removal of zinc was evidenced by the
acquisition of a “clean” Cys4 spectrum containing no
zinc.
Original (uninfused) and infused samples were
treated as analyte solutions so that the relative drop in
zinc concentration from the original and infused sam-
ples could be conveyed. The AAS results (Figure 3)
show that the zinc concentration of a solution drops
after it has been infused. Thus, the ESI potential does
not have to be applied for zinc deposition in the ESI
emitter to occur. The AAS results corroborate the
ESI-MS results: AAS shows zinc is “lost” from solution
after infusion, and ESI-MS results indicate that the lost
zinc is reintroduced to newly infused solution. Addi-
tionally, Figure 3 shows that the drop in zinc concen-
tration from the original to the infused samples was
highest at 0.250 mL/h, which is the flow rate closest to
what is typically used in this source (0.100–0.250 mL/
h). Less zinc was lost as the flow rate increased,
indicating that the timescale of deposition requires
slower flow or that the fast flowing fluid quickly
reincorporates the deposited zinc. The most important
finding is that a significant amount of zinc is lost from
the original sample during its travel through the emitterat typically used flow rates, even when the zinc is
initially bound to a very strong zinc binder like Cys4.
As mentioned above, zinc deposition needed to be
detected with another peptide sequence to confirm this
phenomenon was not somehow unique to the Cys4 se-
quence. We have worked extensively with the 40 amino
acid putative zinc binding region of prothymosin-,
(ProT). This highly acidic, natively unfolded peptide has
been shown to adopt an ordered structure upon zinc
binding, but it does not contain any residues traditionally
involved in zinc-binding such as cysteine, histidine, or
methionine [22, 23]. ProT weakly binds as many as five
zinc ions at pH 7 [24]. To date, a reproducible set of Kd
values for the zinc-binding events has not been estab-
lished, so this work cannot be used to compare current
data with previously observed results. In addition, the
difficulty of synthesizing and preparing this particular
peptide for mass spectral analysis has been the subject of
a previous publication, hence the different solution con-
ditions (e.g., different buffer) used for this peptide versus
the Cys4 [24]. However, this system does provide away to
rule out redox processes involving the peptide as a con-
tributing cause for zinc loss and deposition. Redox chem-
istry must be considered when working with thiol-
containing peptides such as Cys4, which, in the apo-form,
can oxidize to form disulfide bridges.
Several experiments analogous to those conducted
with Cys4 were then conducted in negative ESI mode
with ProT, this nontraditional metal-binding pep-
tide with coordination sites not involving redox ac-
tive residues. Solutions of 20 M ProT and a variety
of molar equivalents of Zn2 (0.1 to 5.0) were indi-
vidually infused, and after only neutral aqueous
washes, solutions of 20 M ProT only were infused
(spectra not shown). As in the Cys4 experiments,
ProT:Zn2 signal reappeared in the absence of Zn2
in solution, and this occurred with the polarity con-
tinually set in the same mode (in this case, negative
Figure 3. Effect of flow rate on the amount of zinc deposited in
the ESI emitter. AAS was used to determine the relative drop in
zinc concentration in the 10 M Cys4:Zn2 solution before and
after positive mode ESI.mode). If the only source of Zn2 ions were redis-
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have been switched from negative to positive. This
leads us to conclude that this phenomenon is inde-
pendent of previously monitored redox processes.
This is not to say that those redox processes could not
concurrently occur under the proper conditions, just
that the deposition happens either in addition to or
altogether separate from the electrochemical process.
After determining that the stainless steel emitter
retains zinc from peptide:zinc solutions during positive
or negative ESI, and with two very different peptide
sequences, a custom-built nanoESI interface using glass
emitters was implemented, thus removing the stainless
steel surfaces from the experiment. Then, a 1:1 Cys4:
Zn2 (10 M each) solution was analyzed by nanoESI,
and the results were compared with ESI-MS. Figure 4
shows a comparison of nanoESI and ESI spectra, where
the different percentages of peptide bound to Zn2 are
seen to vary as a function of electrospray technique and
flow rate. The mean ( standard deviation) of the
percent of Cys4 involved in zinc-binding was calculated
to be 70% (3)% for nanoESI (Figure 4a), but drops to
48% (2)% with ESI (Figure 4b, 0.250 mL/h infusion
rate). When the ESI flow rate was increased dramati-
cally to 2.00 mL/h, the nebulizer gas pressure was
Figure 4. Mass spectra of 1:1 (10 M each) Cys4:Zn2 using (a)
nanoESI, (b) ESI, 0.250 mL/h, and (c) ESI, 2.00 mL/h.doubled to 20 psi and the position of the emitter plume
was moved2 mm away from the sampling aperture to
accommodate the high volume entering the mass spec-
trometer. Under these conditions, the spectrum ac-
quired in Figure 4c shows the percent of peptide signal
due to the Cys4:Zn2 complex increased to 71% (3)%,
the same value observed with nanoESI. Using Kd  8.0
pM and working with 10 M solutions, one would
expect 100% of the peptide to be in the metal-bound
state. The nanoESI and the high-flow rate ESI data show
a lower metal binding percentage than what the equi-
librium calculations suggest, but the value is more in
line with calculated predictions than what the slow-
flow rate ESI spectrum shows. Thus, these data provide
evidence that changing the emitter material and altering
the residence time of the solution in the stainless steel
emitter strongly influence the resulting metal–peptide
signal.
It should be emphasized that the relative comparison
of signal intensities obtained from Figure 4 is valid only
because the same Cys4:Zn2 analyte solutions were used
for both the nanoESI and ESI experiments, and it is the
variation in signal intensities between the ESI and
nanoESI data on which we are focused because of the
observed retention of zinc in the ESI emitter. We can only
use mass spectral intensities from the nanoESI source as
evidence that less (or perhaps no) zinc is retained in the
glass emitter versus the ESI stainless steel emitter. Our
measurements of the absolute percent of peptide ions
binding zinc ions are not expected to be accurate, partly
because analyte solutions were not prepared with autoti-
trators, purchasedmetal salt standards, or under reducing
conditions. However, it was important to choose a very
strong zinc binding peptide (Cys4) so that detection of any
free peptide in the mass spectrum would serve as a red
flag that zinc was being lost during the analysis, regard-
less of whether the peak intensities could be used subse-
quently in a Kd determination.
We can consider the different operating conditions
used for ESI versus nanoESI as a possible cause for
the different results obtained from the two tech-
niques. The dry gas flow rate needed for ESI is five
times higher than what is used in nanoESI, and no
nebulizing gas is used in nanoESI. Typically, lower
source temperatures can be used with the lower flow
technique, as well. None of these parameter changes
are expected to drastically affect the percentage of
intact metal–peptide complex observed in the mass
spectra. A thorough investigation of the effects of the
mechanism of droplet formation and the gentleness
of various ESI techniques on the Kd determination
experiments of various protein–ligand systems has
been performed [25]. While the experiments did not
involve metal-containing complexes, it is relevant
that Kd values for model non-metal systems were
obtained with good agreement between ESI and
nanoESI. For our work, where possible, control ex-
periments were performed to confirm that the change
in emitter material, and not other experimental con-
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niques, is the primary reason for the differences in
ESI and nanoESI signal. For example, when using
nanoESI as the ionization technique, the fraction of
phytochelatin 4 (PC4) signal arising from PC4:Zn2
complex was the same at 50 °C (vide infra) and at
250 °C. Consequently, the generally regarded “gen-
tleness” of the nanoESI source compared with the ESI
source is not the key reason that higher signal inten-
sity is observed from peptide ions with zinc bound to
them. Instead, the emitter material appears to play
the chief role.
The nanoESI-MS technique can even be used to
complement the AAS data by providing a snapshot of
how much zinc is deposited in the ESI stainless steel
emitter. The nine amino acid PC4 was studied in
positive mode. The phytochelatins, found in plants, are
cysteine-rich peptides of varying lengths, which are
capable of binding many different heavy metals [26].
For a 1:1 PC4:Zn2 complex, the dissociation constant is
between 0.5 and 0.9 M [27]. A 10 M PC4 solution
with one equivalent of zinc added was analyzed with
nanoESI, shown in Figure 5a. The average and standard
deviation for the fraction of total peptide signal (eq 1)
arising from the PC4:Zn2 pair was 43% (2)%. Using
the estimated dissociation constant of 0.7 M to calcu-
late the fraction of peptide expected in the bound form,
we arrive at the value of 77%. As with Cys4, the
measurement of only 43% PC4 in complex with Zn2
Figure 5. Mass spectra of 1:1 (10 M each) PC4:Zn2 using
nanoESI (a) before infusion through the ESI emitter and (b) after
infusion. A magnified view of theZn2 peaks from (a) and (b) is
shown in (c).using nanoESI is again lower than the expected value.
But after infusion through the ESI emitter, the percent
of peptide bound to zinc was even lower. A 0.250 mL
aliquot of that same PC4:Zn2 solution was infused
through the ESI emitter at a flow rate of 0.250 mL/h for
1 h with no ESI potential applied and no nebulizer or
dry gas flowing. Sample was collected as described for
the AAS experiments. This sample was then analyzed
with nanoESI (Figure 5b), and the PC4:Zn2 signal
comprised only 17% (3)% of the total peptide signal in
the mass spectra. This represents approximately a 60%
drop in zinc-related signal (Figure 5c), similar to the
50% drop in zinc concentration in the Cys4:Zn2 solu-
tion after infusion at 0.250 mL/h as measured by AAS.
Because of the drop in zinc content of the analyte
solutions after ESI infusion, ESI-MS peak intensities of
these zinc–peptide complexes could not be reliably
used in titration plots or other data analyses depicting
the affinity of the peptide for the metal.
Conclusions
When peptide–zinc complexes were analyzed by ESI,
zinc was deposited in the stainless steel emitter. This
occurred regardless of ESI polarity, ruling out any
compensating electrolytic deposition of the metal. It
occurred for relatively strong zinc-binding peptides
containing cysteine, a typical zinc binding amino acid,
and for a weak zinc-binder that presumably binds
through primarily electrostatic forces. At flow rates
typical of conventional flow ESI, as much as 50% of the
zinc present in the original sample is removed after
infusion through the emitter assembly, before entering
the mass spectrometer. As has been documented for
electrolysis of analytes during ESI, slower flow rates
altered the infused sample composition more dramati-
cally [17]. Using a glass emitter in a nanoESI source
yields a much higher zinc–peptide signal than seen
with ESI. The observation of a low intensity zinc–
peptide signal in the nanoESI analysis of a sample that
had been infused through the ESI emitter assembly
reiterates that nanoESI is not simply gentler on the
complex, but that the zinc was truly removed from the
sample during the infusion step.
Knowing now that for zinc–peptide systems,
nanoESI will yield more reliable results than the use of
a stainless steel emitter in ESI, we will seek to reproduce
previously determined Kd values for zinc–peptide com-
plexes falling in the nanomolar to micromolar range.
This concentration range is above the limit of detection
of nanoESI-MS, so competition experiments will not be
necessary. Additionally, the deposition phenomenon
may extend to other metals, making investigations of
other metal–peptide systems crucial. There is also much
to be learned about metal-binding behavior of phytoch-
elatins that can be provided by mass spectrometry. For
example, mass spectrometry has already been used to
examine the stoichiometry of the PC4:Zn2 complex
when its electroinactivity rendered voltammetric stud-
2205J Am Soc Mass Spectrom 2009, 20, 2199–2205 ZINC DEPOSITION DURING ESI-MSies inconclusive [8]. We can exploit these systems to
both investigate the metal deposition phenomenon and
better describe the metal-binding characteristics of
these phytochelatins.
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